Press Releases

2020

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering

Sigilon Therapeutics 12.03.2020

Flagship Pioneering Unveils Senda Biosciences to Pioneer Intersystems Biology and Create Novel Treatments for Human Disease

Senda Biosciences 10.28.2020

Foghorn Therapeutics Announces Pricing of Initial Public Offering

Foghorn Therapeutics 10.23.2020

Flagship Pioneering Announces Appointment of Tuyen Ong as CEO-Partner

Ring Therapeutics 10.13.2020

Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer

10.01.2020

Flagship Pioneering Announces Valo Health to Transform Drug Development

Valo 09.23.2020

Cygnal Therapeutics Expands Leadership Team With Appointment Of John A. Wagner, M.D., Ph.D., As Chief Medical Officer

09.16.2020

Flagship Pioneering’s Scientists Invent Machine Learning–Powered Platform to Generate Novel Biomedicines

Generate Biomedicines 09.09.2020

Seres Therapeutics Announces Positive Topline Results From SER-109 Phase 3 ECOSPOR III Study In Recurrent C. Difficile Infection

Seres Therapeutics 08.13.2020

Omega Therapeutics Advances Controllable Epigenomic Programming Platform to Deliver a Pipeline of Novel Therapeutics with $85M in Financing

Omega Therapeutics 07.29.2020

Loading